)
)
Blueprint Medicines Investor Relations Material
Latest events
Q3 2024
Blueprint Medicines
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Blueprint Medicines Corp
Access all reports
Blueprint Medicines Corp. is a biopharmaceutical company focused on developing targeted therapies for genomically defined cancers and rare diseases. The company utilizes precision medicine approaches to design small-molecule drugs that inhibit specific genetic drivers of disease. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Blueprint Medicines Corp
Q3 2024
Blueprint Medicines Corp
Q4 2023
Blueprint Medicines Corp
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
BPMC
Country
🇺🇸 United States